Clinical Trial Update: Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of sofosbuvir plus ribavirin in adults co-infected with hepatitis C and HIV; the study has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Ribavirin (ribavirin)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2014-11-21